RESUMEN
Selenium is an essential trace element and selenoprotein S is a member of the selenoprotein family that has the non-standard amino acid selenocysteine incorporated into the polypeptide. Dietary selenium has been shown to play an important protective role in a number of diseases including cancer, immune function and the male reproductive system. In this study, we have observed high levels of selenoprotein S gene expression in the testis from Psammomys obesus. Real-time PCR and immunofluorescence demonstrate that selenoprotein S expression is low in testes from 4-week-old animals but increases significantly by 8 weeks of age and remains high until 17 weeks of age. Selenoprotein S protein is detected in primary spermatocytes, Leydig and Sertoli cells of 8, 12 and 17-week-old animals. These results suggest that selenoprotein S may play a role in spermatogenesis.
Asunto(s)
Envejecimiento/fisiología , Gerbillinae/metabolismo , Selenoproteínas/metabolismo , Espermatogénesis/fisiología , Testículo/patología , Animales , Suplementos Dietéticos , Masculino , Selenio/farmacología , Selenocisteína/metabolismo , Espermatogénesis/efectos de los fármacos , Testículo/citologíaRESUMEN
Increased hepatic glucose output and decreased glucose utilization are implicated in the development of type 2 diabetes. We previously reported that the expression of a novel gene, Tanis, was upregulated in the liver during fasting in the obese/diabetic animal model Psammomys obesus. Here, we have further studied the protein and its function. Cell fractionation indicated that Tanis was localized in the plasma membrane and microsomes but not in the nucleus, mitochondria, or soluble protein fraction. Consistent with previous gene expression data, hepatic Tanis protein levels increased more significantly in diabetic P. obesus than in nondiabetic controls after fasting. We used a recombinant adenovirus to increase Tanis expression in hepatoma H4IIE cells and investigated its role in metabolism. Tanis overexpression reduced glucose uptake, basal and insulin-stimulated glycogen synthesis, and glycogen content and attenuated the suppression of PEPCK gene expression by insulin, but it did not affect insulin-stimulated insulin receptor phosphorylation or triglyceride synthesis. These results suggest that Tanis may be involved in the regulation of glucose metabolism, and increased expression of Tanis could contribute to insulin resistance in the liver.
Asunto(s)
Expresión Génica , Glucosa/metabolismo , Insulina/farmacología , Hígado/metabolismo , Proteínas de la Membrana/genética , Secuencia de Aminoácidos , Animales , Fraccionamiento Celular , Membrana Celular/química , Núcleo Celular/química , Diabetes Mellitus/metabolismo , Gerbillinae , Glucógeno/análisis , Glucógeno/biosíntesis , Hígado/ultraestructura , Proteínas de la Membrana/química , Proteínas de la Membrana/fisiología , Microsomas Hepáticos/química , Mitocondrias Hepáticas/química , Datos de Secuencia Molecular , Obesidad/metabolismo , Fragmentos de Péptidos/química , Fosfoenolpiruvato Carboxiquinasa (GTP)/genética , Fosforilación , Receptor de Insulina/metabolismo , Transfección , Triglicéridos/biosíntesis , Células Tumorales CultivadasRESUMEN
Here we describe a novel protein, which we have named Tanis, that is implicated in type 2 diabetes and inflammation. In Psammomys obesus, a unique polygenic animal model of type 2 diabetes and the metabolic syndrome, Tanis is expressed in the liver in inverse proportion to circulating glucose (P = 0.010) and insulin levels (P = 0.004) and in direct proportion with plasma triglyceride concentrations (P = 0.007). Hepatic Tanis gene expression was markedly increased (3.1-fold) after a 24-h fast in diabetic but not in nondiabetic P. obesus. In addition, glucose inhibited Tanis gene expression in cultured hepatocytes (P = 0.006) as well as in several other cell types (P = 0.001-0.011). Thus, Tanis seems to be regulated by glucose and is dysregulated in the diabetic state. Yeast-2 hybrid screening identified serum amyloid A (SAA), an acute-phase inflammatory response protein, as an interacting protein of Tanis, and this was confirmed by Biacore experiments. SAA and other acute-phase proteins have been the focus of recent attention as risk factors for cardiovascular disease, and we contend that Tanis and its interaction with SAA may provide a mechanistic link among type 2 diabetes, inflammation, and cardiovascular disease.
Asunto(s)
Diabetes Mellitus Tipo 2/etiología , Inflamación/etiología , Proteínas de la Membrana/fisiología , Secuencia de Aminoácidos , Animales , Apolipoproteínas/metabolismo , Secuencia de Bases , Glucemia/análisis , Mapeo Cromosómico , Cromosomas Humanos Par 15 , Exones , Expresión Génica/efectos de los fármacos , Gerbillinae , Glucosa/farmacología , Glicosilación , Humanos , Hígado/química , Hígado/metabolismo , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Datos de Secuencia Molecular , Fosforilación , Reacción en Cadena de la Polimerasa , Estructura Secundaria de Proteína , ARN Mensajero/química , Factores de Riesgo , Alineación de Secuencia , Proteína Amiloide A Sérica/metabolismoRESUMEN
DNA-based approaches to the discovery of genes contributing to the development of type 2 diabetes have not been very successful despite substantial investments of time and money. The multiple gene-gene and gene-environment interactions that influence the development of type 2 diabetes mean that DNA approaches are not the ideal tool for defining the etiology of this complex disease. Gene expression-based technologies may prove to be a more rewarding strategy to identify diabetes candidate genes. There are a number of RNA-based technologies available to identify genes that are differentially expressed in various tissues in type 2 diabetes. These include differential display polymerase chain reaction (ddPCR), suppression subtractive hybridization (SSH), and cDNA microarrays. The power of new technologies to detect differential gene expression is ideally suited to studies utilizing appropriate animal models of human disease. We have shown that the gene expression approach, in combination with an excellent animal model such as the Israeli sand rat (Psammomys obesus), can provide novel genes and pathways that may be important in the disease process and provide novel therapeutic approaches. This paper will describe a new gene discovery, beacon, a novel gene linked with energy intake. As the functional characterization of novel genes discovered in our laboratory using this approach continues, it is anticipated that we will soon be able to compile a definitive list of genes that are important in the development of obesity and type 2 diabetes.